Iterum Therapeutics (ITRM) announced the appointment of Christine Coyne to the newly created position of Chief Commercial Officer, CCO. In this role, Coyne will lead all commercial efforts for Iterum, including the upcoming launch of ORLYNVAH in the United States, as well as future commercialization activities across new products and markets.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.